Enliven Therapeutics shares owned by Stempoint Capital
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Stempoint Capital
from 13F filings
Historical chart of Stempoint Capital investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Stempoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $14M | 363k | 39.20 |
| 2025-03-31 | $2.4M | 120k | 19.68 |
| 2024-12-31 | $2.2M | 97k | 22.50 |